HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Coty’s TJoy Unit Continues To Disappoint, Driving $253.3 Mil. Loss In Q3

This article was originally published in The Rose Sheet

Executive Summary

Coty Inc. recorded a $316.9 million asset write-down in the third fiscal quarter related to its TJoy skin-care business in China, driving a $253.3 million loss overall. The firm will reorganize its mass-market business in the country to improve profitability in Skin & Body Care, which booked an 8% increase in global revenues on the strength of the firm’s philosophy brand, among other highlights, despite TJoy’s drag on the segment’s performance.

You may also be interested in...

Coty Chips Away At Post-Merger Brand Challenges, With Investors Getting Restless

CoverGirl, Max Factor and other pickups from P&G through the firms’ recently closed merger were “neglected” for two to three years as the deal was coming together and being executed, doing no favors for Coty’s newly combined Consumer Beauty business. However, Coty has dispensed with organizational work and is focused on driving growth, management says, projecting improvements in the back half of the year.

Coty Reorganizes To Advance Growth, “Best-In-Class” Category Innovation

Coty Inc.’s new organizational structure is centered on product innovation and “consumer evolution,” the New York firm announces July 9. The restructuring includes a number of executive changes and transforms Coty’s Prestige and Beauty units to a “Categories and Innovation” umbrella comprising four product category branches.

In Brief: FDA On Sunscreen Rule; Brazil Bans Most Animal Tests; More

FDA’s Spring 2014 Unified Agenda sets a March 2015 estimate for issuing a proposed rule on sunscreen active ingredient safety. More news in brief.

Related Content

Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts